Bioethics International

Bioethics International is a 501(c)(3) public charity, founded in 2005, to strengthen ethics, transparency, trust, and patient-centricity in healthcare. We turn core bioethics principles into practical, evidence-based standards that guide, evaluate, and improve how healthcare and life science companies operate across the full medicine lifecycle—from clinical trials to patient access. Through public benchmarking, stakeholder collaboration, and ethical persuasion, we equip industry leaders, policymakers, investors, patients, and the public with tools to align business practices with the highest ethical standards—ensuring that patient health, dignity, and trust remain at the center of innovation. The Good Pharma Scorecard (GPS), is a central initiative, an annual ranking of pharmaceutical companies on their bioethical performance. The Scorecard sets clear, evidence-based benchmarks for what “good” looks like in patient-centered healthcare. We then evaluate and rank company performance, spotlighting leaders, catalyzing reform where it’s needed, and tracking progress over time. The Good Pharma Scorecard drives accountability and improvement by making ethical performance visible, measurable, and competitive—encouraging companies to lead not only in science, but also in responsibility to patients. The impact is clear: industry-wide transparency scores have risen each year. In one example, half of the lower-scoring companies in 2019 improved their data-sharing practices within 30 days of receiving their Scorecard results. Companies display their GPS Leaderboard badges in CEO letters, annual reports, and SEC filings. Building on momentum, BEI launched the Bioethics Leadership Forum, an invited community of leaders across academia, industry, patients, healthcare, policy, and investment to support our mission. Together, we are redefining what ethical leadership looks like, ensure progress in science is matched by progress in trust and patient centricity.